RxDoctor Payments Data

Paul Hoffman

Physician Assistant · Houston, TXNPI 1144249509

Payments from drug & device makers

$1,341in general payments, 2019–2025

Across 60 payments — averaging $22.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$462
  • Abbott$115
  • Otsuka America Pharmaceutical, Inc.$99
  • Novo Nordisk$93
  • Boehringer Ingelheim$57
  • Lilly USA, LLC$56
  • plus $459 from 18 others

What the payments were for

  • Food & beverage$1,341100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,341 in reported general payments places this provider in the 70th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide19$47,242
JardianceEmpagliflozin19$34,278
OzempicSemaglutide17$31,622
FarxigaDapagliflozin Propanediol23$29,362
Celecoxib47$2,139
Gabapentin68$1,412
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,171
Mirtazapine21$1,155
Vitamin D2Ergocalciferol (Vitamin D2)77$1,143
Diclofenac Sodium42$1,121
Albuterol Sulfate HfaAlbuterol Sulfate27$1,077
Atorvastatin Calcium175$1,048
Metformin Hcl168$742
Fluticasone Propionate38$640
Omeprazole32$590

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$56$47,24219 claims
Boehringer IngelheimJardiance$57$34,27819 claims
Novo NordiskOzempic$93$31,62217 claims
AstraZenecaFarxiga$462$29,36223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →